STOCK TITAN

Jeremy Chadwick reports KYMR transactions (NASDAQ: KYMR) including 20,000-option line

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Jeremy Chadwick reported proposed and recent transactions in shares of KYMR. The filing lists a proposed exercise-related sale of 20,000 common shares dated 03/11/2026 and shows restricted stock units dated 05/22/2024 totaling 5,758 units.

The filing also records completed sales: 3,919 shares on 03/04/2026 for $334,272.49 and 2,039 shares on 03/02/2026 for $181,321.64.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What transactions did Jeremy Chadwick report for KYMR?

Jeremy Chadwick reported proposed and completed transactions. The filing lists a proposed exercise-related sale of 20,000 shares dated 03/11/2026 and completed sales of 3,919 shares on 03/04/2026 and 2,039 shares on 03/02/2026.

How much cash did Chadwick receive from the reported KYMR sales?

The filing shows proceeds of $334,272.49 for 3,919 shares sold on 03/04/2026 and $181,321.64 for 2,039 shares sold on 03/02/2026, as disclosed in the transaction lines of the Form 144 excerpt.

Does the filing show any equity awards related to KYMR holdings?

Yes. The excerpt lists 5,758 restricted stock units dated 05/22/2024. It also records an exercise-of-options line tied to 20,000 common shares dated 03/11/2026 in the securities-to-be-sold section.

Who is listed as the broker or intermediary in the KYMR filing?

The excerpt names Morgan Stanley Smith Barney LLC at 1 New York Plaza, 8th Floor, New York, NY 10004 as the listed financial intermediary for the transactions shown in the Form 144 content.
Kymera Therapeutics, Inc.

NASDAQ:KYMR

View KYMR Stock Overview

KYMR Rankings

KYMR Latest News

KYMR Latest SEC Filings

KYMR Stock Data

6.45B
79.49M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
WATERTOWN